FOXL1, a Novel Candidate Tumor Suppressor, Inhibits Tumor Aggressiveness and Predicts Outcome in Human Pancreatic Cancer
Geng Zhang(Hebei Medical University), S. Perwez Hussain(National Institutes of Health), Thomas Ried(National Institutes of Health), Harris G. Yfantis(University of Maryland, Baltimore), B. Michael Ghadimi(Universitätsmedizin Göttingen), Peijun He(University of Maryland, Baltimore), H. Richard Alexander(Umeå University), Nader Hanna(University of Maryland, Baltimore), Dong Hoon Lee(Korea University), Jochen Gaedcke(Universitätsmedizin Göttingen)
Cited by 47
Related Papers
Multiple Cytokines and Acute Inflammation Raise Mouse Leptin Levels: Potential Role in Inflammatory Anorexia
|The Journal of Experimental Medicine|1997|797
Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer
|Cancer Research|2008|708
ErbB receptors: from oncogenes to targeted cancer therapies
|Journal of Clinical Investigation|2007|578